IOL Chemicals and Pharmaceuticals · NSE: IOLCP · BSE: 524164
Q4 FY24 results · Jan–Mar 2024
IOL Chemicals and Pharmaceuticals reported revenue from operations of ₹503.92 crore (down 14.2% from Q4 FY23) and net profit of ₹27.62 crore (down 57.4% from Q4 FY23) for Q4 FY24 (Jan–Mar 2024), on a consolidated basis.
| Item | Q4 FY24 | Q4 FY23 | YoY | Q3 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 503.92 | 587.21 | −14.2% | 520.39 | −3.2% |
| Other income | 7.52 | 8.73 | −13.9% | 8.38 | −10.3% |
| Total income | 511.44 | 595.94 | −14.2% | 528.77 | −3.3% |
| Profit before tax | 37.20 | 87.04 | −57.3% | 32.09 | +15.9% |
| Net profit for the period | 27.62 | 64.78 | −57.4% | 23.08 | +19.7% |
| EPS, basic (₹) | 4.71 | 11.03 | −57.3% | 3.93 | +19.8% |
| Net margin (%) | 5.5 | 11.0 | 4.4 |
| Item | Q4 FY24 | Q4 FY23 | YoY | Q3 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 503.92 | 587.21 | −14.2% | 520.39 | −3.2% |
| Other income | 7.52 | 8.72 | −13.8% | 8.38 | −10.3% |
| Total income | 511.44 | 595.93 | −14.2% | 528.77 | −3.3% |
| Profit before tax | 37.77 | 87.53 | −56.8% | 32.24 | +17.2% |
| Net profit for the period | 28.19 | 65.27 | −56.8% | 23.23 | +21.4% |
| EPS, basic (₹) | 4.80 | 11.11 | −56.8% | 3.96 | +21.2% |
| Net margin (%) | 5.6 | 11.1 | 4.5 |
Consolidated
- Filed with BSE
- 15 May 2024, 12:42 IST
- Board meeting
- 14 May 2024
- Period
- 01 Jan 2024 to 31 Mar 2024
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 15 May 2024, 12:42 IST
- Board meeting
- 14 May 2024
- Period
- 01 Jan 2024 to 31 Mar 2024
- Review status
- Audited
- Source
- XBRL filing on BSE